中期因子,Midkine
1)Midkine中期因子
1.Effects of siRNA targeting midkine on apoptosis and chemosensitivity in SW620 colonal cancer cells;RNAi沉默中期因子基因表达对结肠癌细胞凋亡和化疗敏感性的影响
2.Expression and significance of midkine and microvessel density in osteosarcoma;中期因子和微血管密度在骨肉瘤中的表达及其意义(英文)
3.Expression of Midkine in Gastric Cancer and Its Clinical Significance;中期因子在胃癌中的表达及其意义
英文短句/例句

1.Expressions of Midkine in Human Gastric Carcinoma and Its Clinical Significance中期因子在胃癌中的表达及临床意义
2.Expression of Midkine in Gallbladder Carcinoma and Its Significance;中期因子蛋白在胆囊癌的表达及意义
3.The Quantitive Measurement of Midkine and Its Expression in Preeclampsia中期因子(MK)在子痫前期患者中的定量检测及表达
4.The Quantitive Measurement of Midkine and Its Expression in Gastric Carcinoma and Colon Carcinoma;中期因子在胃癌和结肠癌中的定量检测及表达
5.The Expression of Midkine in Gastric Cancer and Its Clinical Significance;中期因子在胃癌组织中的表达及其临床意义
6.Study on Expression of Midkine and Microvessel density in breast Carcinoma;中期因子和微血管密度在乳腺癌中表达的研究
7.Expression of midkine in meningioma and its biological value脑膜瘤组织中中期因子蛋白的表达及意义
8.Expression and significance of midkine and MVD in gastric carcinoma中期因子及MVD在胃癌中的表达及临床意义
9.Expression and Clinical Significance of Midkine in Thyroid Gland Carcinoma妊娠中期因子在甲状腺癌中的表达及其意义
10.Effects of siRNA Targeted Midkine on Biological Behavior of Breast Carcinoma中期因子靶向siRNA对乳腺癌生物学行为的影响
11.Influence of Midkine on Proliferation and Apotosis of Lung Adenocarcinoma Cell Lines A_(549)中期因子对肺腺癌A549细胞增殖凋亡的影响
12.An Initial Probe Into the Reasons of Chinese Intellectuals Change in the Early Stage of the Republic;建国初期中国知识分子转变原因初探
13.Role of Tumor Necrosis Factor-alpha in Pathogenesis of Preeclampsia肿瘤坏死因子α在子痫前期发生发展中的作用
14.Application of multi-factor stepwise regression cycle analysis in medium and long-term hydrological forecast多因子逐步回归周期分析在中长期水文预报中的应用
15.Expression of the Regulation Factors CyclinD1, p27 and p16 of Cell Cycle in the Colorectal Carcinoma;细胞周期调控因子cyclinD1、p27、p16在大肠癌中的表达
16.The Expression of HOXA 11 in Human Endometrium of the Menstrual Cycle;同源框基因HOXA11在月经周期人子宫内膜中的表达
17.The Expression of M-Phase Promoting Factor in Salivary Adenoid Cystic Carcinoma;M期促进因子在涎腺腺样囊性癌中的表达
18.The Changes of Insulin-like Growth Factor-2 in Early Pregnancy;孕早期血中胰岛素样生长因子-Ⅱ的浓度变化
相关短句/例句

MK中期因子
1.Clinical Significance of MK Expression in Gastric Carcinoma;中期因子在胃癌中的表达及其临床意义
2.Clinical Significance of MK, Ang-2 and VEGF Expression in Gastric Carcinoma;中期因子、血管生成素-2和血管内皮生长因子在胃癌中的表达及意义
3.Objective To investigate the correlation between midkine(MK) and VEGF expression with angiogenesis and biological features in recurrent gastric carcinoma.目的研究中期因子(midkine,MK)和血管内皮生长因子(VEGF)在复发性胃癌组织中的表达情况,并探讨其临床意义。
3)Midkine(MK)中期因子(MK)
4)Midkine妊娠中期因子
1.Study of the Expression of Midkine in Thyroid Gland Carcinoma;妊娠中期因子在甲状腺癌中的表达研究
2.Expression and Clinical Significance of Midkine in Thyroid Gland Carcinoma妊娠中期因子在甲状腺癌中的表达及其意义
5)Midkine中期因子蛋白
1.Expression of midkine and microvesseldensity in non-small cell lung cancer and significance;非小细胞肺癌组织中期因子蛋白表达及其临床意义的研究
2.Expression of midkine in meningioma and its biological value脑膜瘤组织中中期因子蛋白的表达及意义
6)Medium-term factor中期因素
延伸阅读

正常人白细胞转移因子 , 白细胞转移因子,转移因子药物名称:转移因子英文名:Transfer Factor别名: 正常人白细胞转移因子 , 白细胞转移因子,转移因子外文名:Transfer Factor ,TF适应症: 为细胞免疫反应增强剂,能将细胞免疫活性转移给受体,以提高受体的免疫功能。临床上用于治疗某些抗生素难以控制的病毒性或酶菌性细胞内感染(如带状皰疹、流行性乙型脑炎、白色念珠菌感染等)。对恶性肿瘤可作为辅助治疗剂,对自体免疫性疾病也有一定治疗作用。 用量用法: 一般采用皮下注射,注于上臂内侧或大腿内侧腹股沟下端,1次注射1支,每周1~2次,1个月后改为每2周1次。对带状疱疹,一般只需注射1次。 规格: 注射液:每支2ml,相当于1×1000000000白细胞提取物(上海产),北京产则相当于5~10×1000000000. 注:严禁静脉给药.类别:免疫调节剂